-The Economic Times DANTEWADA: With both the Congress and BJP advocating an intensification of the military campaign against the Naxals, and the UPA government at the Centre even committing more troops to Chhattisgarh, local development in the state could become a casualty in the crossfire. "An outside force is less capable of discriminating between Naxals and villagers," says Vishwa Ranjan, former director general police, Chhattisgarh. Such an intensification will result in greater...
More »SEARCH RESULT
Total Matching Records found : 1494
Meat, market threat to Arunachal species -GS Mudur
-The Telegraph Illegal hunting in Arunachal Pradesh primarily for meat on the table or for money from the market may be threatening several protected or rare wildlife species, a survey in the state's Ziro Valley has indicated. Researchers from the Wildlife Institute of India, (WII) Dehradun, have documented hunting of leopards, marbled cats, black bears, orange-bellied squirrels, among other species, mainly for meat, skin, and commercial sales in six villages of Ziro...
More »Depositors from outside add to complaint pile
-The Indian Express Kolkata: AMONG the 6.25 lakh complaints received by Justice Sen Commission, which has been set up by the West Bengal government to inquire into the Saradha Group and other chit fund scams and also to look into ways to return money to investors, many have been submitted by people from other states where the firms were operating. "Since the West Bengal government is the only state government that has...
More »Ranbaxy case may take a toll on other Indian drug makers
-The Business Standard The tussle between the US Food and Drug Administration (US FDA) and Ranbaxy is likely to hit the plans of Indian pharmaceutical companies of making it big in the US generic drugs market. Apart from the fact that their image may take a beating, the additional scrutiny on abbreviated new drug applications (ANDAs) from India would lead to more delays in drug approvals. Last week, Ranbaxy had agreed to...
More »Ranbaxy's dark chapter-Bhupesh Bhandari
-The Business Standard Why have Indian authorities woken up to the Ranbaxy case only now? The matter had been simmering for several years The Ranbaxy affair is one of the darkest chapters of India's business history. The company has admitted it fudged data so that it could launch its products in the United States. It has now paid $500 million as a penalty to settle the case. It is worse than Ramalinga...
More »
